Takeuchi Y - Search Results

1

A tool with many applications: vesicular stomatitis virus in research and medicine.

Munis AM, Bentley EM, Takeuchi Y. Munis AM, et al. Among authors: takeuchi y. Expert Opin Biol Ther. 2020 Oct;20(10):1187-1201. doi: 10.1080/14712598.2020.1787981. Epub 2020 Jul 9. Expert Opin Biol Ther. 2020. PMID: 32602788 Review.

2

Characterization of Antibody Interactions with the G Protein of Vesicular Stomatitis Virus Indiana Strain and Other Vesiculovirus G Proteins.

Munis AM, Tijani M, Hassall M, Mattiuzzo G, Collins MK, Takeuchi Y. Munis AM, et al. Among authors: takeuchi y. J Virol. 2018 Nov 12;92(23):e00900-18. doi: 10.1128/JVI.00900-18. Print 2018 Dec 1. J Virol. 2018. PMID: 30232190 Free PMC article.

3

Lentivector Producer Cell Lines with Stably Expressed Vesiculovirus Envelopes.

Tijani M, Munis AM, Perry C, Sanber K, Ferraresso M, Mukhopadhyay T, Themis M, Nisoli I, Mattiuzzo G, Collins MK, Takeuchi Y. Tijani M, et al. Among authors: takeuchi y. Mol Ther Methods Clin Dev. 2018 Aug 7;10:303-312. doi: 10.1016/j.omtm.2018.07.013. eCollection 2018 Sep 21. Mol Ther Methods Clin Dev. 2018. PMID: 30182034 Free PMC article.

4

Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery.

Munis AM, Mattiuzzo G, Bentley EM, Collins MK, Eyles JE, Takeuchi Y. Munis AM, et al. Among authors: takeuchi y. Mol Ther Nucleic Acids. 2019 Sep 6;17:126-137. doi: 10.1016/j.omtn.2019.05.010. Epub 2019 May 28. Mol Ther Nucleic Acids. 2019. PMID: 31254925 Free PMC article.

5

Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike.

Mekkaoui L, Bentley EM, Ferrari M, Lamb K, Ward K, Karattil R, Akbar Z, Bughda R, Sillibourne J, Onuoha S, Mattiuzzo G, Takeuchi Y, Pule M. Mekkaoui L, et al. Among authors: takeuchi y. Bio Protoc. 2021 Aug 20;11(16):e4194. doi: 10.21769/BioProtoc.4194. eCollection 2021 Aug 20. Bio Protoc. 2021. PMID: 34541054 Free PMC article.

6

Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.

Ferrari M, Mekkaoui L, Ilca FT, Akbar Z, Bughda R, Lamb K, Ward K, Parekh F, Karattil R, Allen C, Wu P, Baldan V, Mattiuzzo G, Bentley EM, Takeuchi Y, Sillibourne J, Datta P, Kinna A, Pule M, Onuoha SC. Ferrari M, et al. Among authors: takeuchi y. J Virol. 2021 Sep 9;95(19):e0068521. doi: 10.1128/JVI.00685-21. Epub 2021 Sep 9. J Virol. 2021. PMID: 34287040 Free PMC article.

7

Special Issue "Lentiviral Vectors".

Takeuchi Y. Takeuchi Y. Viruses. 2022 Jul 8;14(7):1492. doi: 10.3390/v14071492. Viruses. 2022. PMID: 35891475 Free PMC article.

8

A lentiviral vector pseudotype suitable for vaccine development.

Lopes L, Dewannieux M, Takeuchi Y, Collins MK. Lopes L, et al. Among authors: takeuchi y. J Gene Med. 2011 Mar;13(3):181-7. doi: 10.1002/jgm.1553. J Gene Med. 2011. PMID: 21394858

9

[Gene therapy using retrovirus vectors: vector development and biosafety at clinical trials].

Doi K, Takeuchi Y. Doi K, et al. Among authors: takeuchi y. Uirusu. 2015;65(1):27-36. doi: 10.2222/jsv.65.27. Uirusu. 2015. PMID: 26923955 Free article. Review. Japanese.

10

Gene transduction efficiency in cells of different species by HIV and EIAV vectors.

Ikeda Y, Collins MK, Radcliffe PA, Mitrophanous KA, Takeuchi Y. Ikeda Y, et al. Among authors: takeuchi y. Gene Ther. 2002 Jul;9(14):932-8. doi: 10.1038/sj.gt.3301708. Gene Ther. 2002. PMID: 12085241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,025 results

Search Page